Literature DB >> 20219325

Polymorphisms of FAS and FAS ligand genes and risk of skin cancer.

Abrar Qureshi, Hongmei Nan, Michael Dyer, Jiali Han.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20219325      PMCID： PMC2920452          DOI： 10.1016/j.jdermsci.2010.01.003

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  10 in total

1.  Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

Authors:  H H Nelson; K T Kelsey; M H Bronson; L A Mott; M R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

2.  Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study.

Authors:  Jiali Han; Graham A Colditz; David J Hunter
Journal:  Int J Epidemiol       Date:  2006-08-30       Impact factor: 7.196

Review 3.  Sun exposure and skin cancer.

Authors:  B K Armstrong; A Kricker; D R English
Journal:  Australas J Dermatol       Date:  1997-06       Impact factor: 2.875

Review 4.  Role of apoptosis in basal cell and squamous cell carcinoma formation.

Authors:  Peter Erb; Jingmin Ji; Marion Wernli; Erwin Kump; Andrea Glaser; Stanislaw A Büchner
Journal:  Immunol Lett       Date:  2005-08-15       Impact factor: 3.685

5.  Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo.

Authors:  Y Aragane; A Maeda; C Y Cui; T Tezuka; Y Kaneda; T Schwarz
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

6.  UV induced bystander signaling leading to apoptosis.

Authors:  Gautam Banerjee; Nishma Gupta; Arun Kapoor; Govindarajan Raman
Journal:  Cancer Lett       Date:  2004-11-23       Impact factor: 8.679

7.  Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.

Authors:  Q R Huang; D Morris; N Manolios
Journal:  Mol Immunol       Date:  1997-06       Impact factor: 4.407

8.  Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.

Authors:  Chunying Li; Derek Larson; Zhengdong Zhang; Zhensheng Liu; Sara S Strom; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Merrick I Ross; Paul F Mansfield; Janice N Cormier; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  Pharmacogenet Genomics       Date:  2006-04       Impact factor: 2.089

9.  A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients.

Authors:  Jianming Wu; Christine Metz; Xiulong Xu; Riichiro Abe; Andrew W Gibson; Jeffrey C Edberg; Jennifer Cooke; Fenglong Xie; Glinda S Cooper; Robert P Kimberly
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

10.  Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Authors:  Kathryn Sibley; Sara Rollinson; James M Allan; Alexandra G Smith; Graham R Law; Philippa L Roddam; Christine F Skibola; Martyn T Smith; Gareth J Morgan
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701
  10 in total
  5 in total

1.  Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.

Authors:  Tao Liu; Li Zuo; Lin Li; Lei Yin; Kai Liang; Hongyuan Yu; Hui Ren; Wen Zhou; Hongwei Jing; Yang Liu; Chuize Kong
Journal:  Tumour Biol       Date:  2014-08-02

2.  Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.

Authors:  Prajitha Mohandas Edathara; Manjula Gorre; Sailaja Kagita; Sugunakar Vuree; Anuradha Cingeetham; Santhoshi Rani Nanchari; Phanni Bhushann Meka; Sandhya Annamaneni; Raghunadha Rao Digumarthi; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2015-11-13

3.  FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.

Authors:  Lei Xu; Xin Zhou; Feng Jiang; Man-Tang Qiu; Zhi Zhang; Rong Yin; Lin Xu
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

Review 4.  FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.

Authors:  Zhou Zhong-Xing; Mi Yuan-Yuan; Ma Hai Zhen; Zou Jian-Gang; Zhang Li-Feng
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

Review 5.  Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.

Authors:  Yeqiong Xu; Bangshun He; Rui Li; Yuqin Pan; Tianyi Gao; Qiwen Deng; Huiling Sun; Guoqi Song; Shukui Wang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.